DEXCOM INC's ticker is and the CUSIP is 252131AH0.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $44,000 | -38.9% | 23,000 | 0.0% | 0.00% | – |
| Q2 2023 | $72,000 | +24.1% | 23,000 | 0.0% | 0.00% | – |
| Q1 2023 | $58,000 | -7.9% | 23,000 | 0.0% | 0.00% | – |
| Q4 2022 | $63,000 | +37.0% | 23,000 | 0.0% | 0.00% | – |
| Q3 2022 | $46,000 | +9.5% | 23,000 | 0.0% | 0.00% | – |
| Q2 2022 | $42,000 | -41.7% | 23,000 | 0.0% | 0.00% | – |
| Q1 2022 | $72,000 | -5.3% | 23,000 | 0.0% | 0.00% | – |
| Q4 2021 | $76,000 | 0.0% | 23,000 | 0.0% | 0.00% | – |
| Q3 2021 | $76,000 | +26.7% | 23,000 | 0.0% | 0.00% | – |
| Q2 2021 | $60,000 | -96.9% | 23,000 | -97.4% | 0.00% | -100.0% |
| Q1 2021 | $1,935,000 | +377.8% | 878,000 | +393.3% | 0.00% | – |
| Q4 2020 | $405,000 | -92.6% | 178,000 | -94.3% | 0.00% | -100.0% |
| Q1 2020 | $5,503,000 | +86.4% | 3,148,000 | +58.2% | 0.00% | +200.0% |
| Q4 2019 | $2,953,000 | – | 1,990,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Elequin Capital, LP | 11,771,000 | $26,632,270 | 5.17% |
| Calamos Advisors LLC | 30,006,000 | $67,881,974 | 0.35% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 5,000,000 | $11,302,500 | 0.05% |
| D. E. Shaw & Co., Inc. | 10,000,000 | $23,351,070 | 0.02% |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 23,000,000 | $52,692,310 | 0.02% |
| BNP PARIBAS FINANCIAL MARKETS | 1,035,000 | $2,337,030 | 0.00% |
| LOOMIS SAYLES & CO L P | 9,739 | $909 | 0.00% |
| JPMORGAN CHASE & CO | 7,065,000 | $13,564,800 | 0.00% |
| FMR LLC | 6,019,000 | $13,590,902 | 0.00% |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 200,000 | $451,600 | 0.00% |